Stocks
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 0.83 | 1.58 | 1.01 | 0.52 | -0.02 | -0.22 | ||
| Changes by years, y/y, % | -37% | +90% | -36% | -49% | -104% | |||
Atara Biotherapeutics. Debt/EBITDA
Atara Biotherapeutics. Debt/EBITDA, changes, %
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 0.48 | 0.29 | 0.14 | -0.02 | -0.22 | -0.22 | ||
| Changes by years, y/y, % | -42% | -62% | -76% | -104% | -145% | |||
| Changes by quarters, q/q, % | -9% | -38% | -52% | -116% | +845% | |||
